News

Largest Franchise Lab Testing Group Formed by ARCpoint and ALTN

Largest Franchise Lab Testing Group Formed by ARCpoint and ALTN

ARCpoint and Any Lab Test Now Form Major Joint Venture

ARCpoint Inc. (TSXV: ARC) is thrilled to announce a significant partnership with Any Lab Test Now (ALTN), merging their franchise operations into a new joint venture named CRESSO Brands, LLC.

Combining Strengths for Enhanced Economic Performance

Clarissa Bradstock, CEO of Any Lab Test Now, emphasized the benefits of this collaboration. She stated that the merger aims to utilize the distinct strengths of both franchises to improve the performance of individual units and boost overall economic efficiency. This partnership is anticipated to provide considerable advantages to ARCpoint’s franchisees and customers through enhanced service offerings.

Overview of Any Lab Test Now

Founded in 1992, Any Lab Test Now has grown to encompass over 235 franchises across the United States, offering convenient clinical, DNA, drug, and alcohol testing services. The company has consistently ranked among the top franchises in the Entrepreneur Franchise 500, reflecting its strong reputation and operational success.

Strategic Advantages for Shareholders

John Constantine, CEO of ARCpoint, noted that this merger is set to introduce cost efficiencies and advantages for ARCpoint shareholders. The joint venture will not only lower costs but also expand the distribution network by utilizing ARCpoint’s proprietary technology platform, MyARCpointLabs.

Leadership of the New Joint Venture

According to the merger agreement, CRESSO Brands will be owned 70.5% by ALTN and 29.5% by ARCpoint. Both brands will keep their independent management structures, with Bradstock and Constantine continuing to oversee their respective franchises while reporting to a five-member board of directors.

Integrating Technology for Franchisees

The agreement also includes plans for ALTN and ARCpoint to implement MyARCpointLabs as the technological backbone for all CRESSO brand franchisees, thereby improving operational efficiency.

About Any Lab Test Now

Any Lab Test Now specializes in direct access lab testing, offering a broad range of standard lab tests while prioritizing professional and transparent service. With a network of over 235 franchise locations, they provide various affordable testing options, including blood work, drug screenings, and STD testing.

About ARCpoint Inc.

ARCpoint Inc. is a leading franchise system dedicated to drug testing, alcohol screening, DNA and clinical lab testing, as well as corporate wellness programs. Established in Greenville, South Carolina, ARCpoint supports more than 130 franchises and is committed to providing innovative solutions to its partners and clients.

For more information, please reach out to:

ARCpoint Inc.
Jason Tong, Chief Financial Officer
Phone: (604) 889-7827
E-mail: invest@arcpointlabs.com

Frequently Asked Questions

What is the significance of the joint venture between ARCpoint and Any Lab Test Now?

The joint venture aims to establish the largest franchise direct access lab testing group in the U.S., enhancing service offerings and operational efficiencies.

How will franchisees benefit from this merger?

Franchisees will gain access to enhanced technology platforms and operational synergies, ultimately improving their service delivery and economic performance.

Who will lead the new joint venture company, CRESSO?

The venture will be co-led by Clarissa Bradstock from Any Lab Test Now and John Constantine from ARCpoint, ensuring that both brands retain their experienced leadership.

What services does Any Lab Test Now provide?

They offer a comprehensive range of lab testing services, including clinical tests, DNA testing, drug screenings, and STD testing across their franchises.

What does ARCpoint focus on?

ARCpoint specializes in drug and alcohol testing, corporate wellness, DNA testing, and employment screening, among other services, while promoting innovative solutions to its clients.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 108

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 20

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 83

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 58

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 135

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 0

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 138

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading

Top 5 Most Recently Viewed Articles

MAGNA-TILES Unveils Exciting Rail Racers To Transform Play

Updated Category News Views 562

MAGNA-TILES Innovates Play with Rail Racers Launch First Fan-Made Invention Reimagines Ball Runs and Takes Magnetic Building to the Next Level MAGNA-TILES, America’s favorite magnetic building toy brand, has introduced an exciting innovation—the Rail Racers. This remarkable new product debuted at the American International Toy Fair, showcasing the creativity of the...

Continue Reading
Discover DDB Miner’s Innovative Approach to Bitcoin Mining

Updated Category News Views 167

Unlocking the Future of Bitcoin Mining DDB Miner, a forward-thinking Bitcoin mining entity, is making significant strides in the cryptocurrency industry. By emphasizing low-cost and efficient operations, DDB Miner is set on a path to redefine how Bitcoin is mined. Their latest operational update sheds light on impressive developments and ambitious plans that promise to...

Continue Reading
Warren Buffett Plans Charitable Giving with New CEO Transition

Updated Category News Views 217

Warren Buffett Speeds Up Charitable Contributions Warren Buffett recently announced that he will accelerate the distribution of his vast fortune, amounting to $149 billion, to his children's charitable foundations. This strategic decision aligns with the responsibilities he feels as a father, recognizing the increasing ages of his children. The Transition to Greg Abel As...

Continue Reading
Understanding the DeFi Technologies Class Action and Its Impact

Updated Category News Views 238

DeFi Technologies Class Action Explained Robbins LLP recently brought to light a class action lawsuit on behalf of investors who bought or acquired shares of DeFi Technologies Inc. (NASDAQ: DEFT). This action covers a specific timeframe, reflecting concerns over the company’s alleged misrepresentation of its business prospects. Investors seeking clarity on this...

Continue Reading
Alibaba's Robotics Innovation: Shaping the Future of AI Tech

Updated Category News Views 199

Alibaba's Bold Move into Robotics Alibaba Group (NYSE: BABA) has embarked on an exciting new venture by launching its own robotics team to compete in the rapidly advancing field of AI-powered physical products. This initiative reflects Alibaba's commitment to integrating artificial intelligence into everyday applications, transforming how technology interacts with the...

Continue Reading